Years Active: 2023-2024
Title: Alaina Ingebritson: Innovator in Bacterial Vaccine Development
Introduction
Alaina Ingebritson is a notable inventor based in Hubbard, IA (US). She has made significant contributions to the field of bacterial infections and vaccine development. With a focus on improving health outcomes in livestock, particularly pigs, her work is paving the way for advancements in veterinary medicine.
Latest Patents
Alaina holds 2 patents that focus on attenuating bacterial virulence by targeting bacterial folate transport. Her inventions relate to bacterial infections and vaccines designed to combat these infections. Specifically, her patents provide a ΔFolT mutant of a bacterium that has a reduced capacity to transport folate. This reduction is achieved by functionally deleting the folate transporter (FolT) function. The methods she developed aim to reduce the virulence of bacteria by limiting their ability to transport folate, which is crucial for their survival and proliferation.
Career Highlights
Throughout her career, Alaina has demonstrated a commitment to innovation in the field of microbiology. Her research has the potential to significantly impact the health of livestock, thereby improving agricultural practices and food safety.
Collaborations
Alaina has collaborated with notable colleagues, including Axel Neubauer and Hilda Elizabeth Smith. Their combined expertise has contributed to the success of her research and the development of her patents.
Conclusion
Alaina Ingebritson is a pioneering inventor whose work in bacterial vaccine development is making strides in veterinary medicine. Her innovative approaches to reducing bacterial virulence are essential for enhancing livestock health and safety.